THE IMPACT
of Guillain-Barré Syndrome (GBS)
Russ, GBS survivor and
patient advocate

COMMITTED TO HELPING PEOPLE WITH GBS
LIVE THEIR BEST LIVES

Annexon is working to deliver game-changing therapies for millions of people living with serious neuroinflammatory diseases of the body, brain and eye. This includes our flagship investigational candidate for GBS, and a next wave of programs targeting neurodegenerative diseases.

Learn how Russ navigates the challenges and hope of being a GBS survivor and patient advocate, including living with the burden of this rare disease, advocating for more disease education and awareness to improve early diagnosis and driving more innovation in treatment.

In the GBS community, we like to say it’s only rare until it happens to you.

Visit the GBS/CIDP Foundation website to learn more about the signs, symptoms and burden of GBS.

Explore our pioneering science focused on the complement cascade
See our full pipeline of first-in-kind therapies